Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mepenzolate bromide 25mg tablets
0102000R0AAABAB
|
Mepenzolate bromide | Mepenzolate bromide | Gastro-Intestinal System | No data available |
|
Merbentyl 10mg tablets
0102000J0BBAAAB
|
Merbentyl | Dicycloverine hydrochloride | Gastro-Intestinal System | No data available |
|
Merbentyl 10mg/5ml syrup
0102000J0BBABAA
|
Merbentyl | Dicycloverine hydrochloride | Gastro-Intestinal System | No data available |
|
Merbentyl 20 tablets
0102000J0BBAEAC
|
Merbentyl | Dicycloverine hydrochloride | Gastro-Intestinal System | No data available |
|
Mesalazine 300mg/5ml oral suspension
0105010B0AABBBB
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | No data available |
|
Mesalazine 400mg/5ml oral liquid
0105010B0AAAMAM
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | No data available |
|
Methylcellulose 100mg/5ml oral liquid
0106010H0AAAKAK
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 112.5mg/5ml oral liquid
0106010H0AAALAL
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 168.75mg/5ml oral liquid
0106010H0AAAVAV
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 2% oral gel
0106010H0AABNBN
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 200mg/5ml oral solution
0106010H0AAAIAI
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 20mg/5ml oral liquid
0106010H0AABKBK
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 225mg/5ml oral liquid
0106010H0AAAMAM
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 250mg/5ml oral liquid
0106010H0AAATAT
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 25mg/5ml oral liquid
0106010H0AAAYAY
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 270mg/5ml oral liquid
0106010H0AAAXAX
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 300mg/5ml oral solution
0106010H0AAAUAU
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 350mg/5ml oral liquid
0106010H0AABMBM
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 450mg/5ml oral solution
0106010H0AAAJAJ
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 45mg/5ml oral liquid
0106010H0AAASAS
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 500mg/5ml oral liquid
0106010H0AABLBL
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 50mg/5ml oral liquid
0106010H0AAAWAW
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 900mg/5ml oral liquid
0106010H0AAAPAP
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Methylcellulose 950mg/5ml oral liquid
0106010H0AAANAN
|
Methylcellulose | Methylcellulose | Gastro-Intestinal System | No data available |
|
Mezzopram 20mg dispersible gastro-resistant tab (NorthStar)
0103050P0BGAEAN
|
Mezzopram | Omeprazole | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.